108 related articles for article (PubMed ID: 21298686)
1. Efflux mediated adaptive and cross resistance to ciprofloxacin and benzalkonium chloride in Pseudomonas aeruginosa of dairy origin.
Pagedar A; Singh J; Batish VK
J Basic Microbiol; 2011 Jun; 51(3):289-95. PubMed ID: 21298686
[TBL] [Abstract][Full Text] [Related]
2. Adaptation to benzalkonium chloride and ciprofloxacin affects biofilm formation potential, efflux pump and haemolysin activity of Escherichia coli of dairy origin.
Pagedar A; Singh J; Batish VK
J Dairy Res; 2012 Nov; 79(4):383-9. PubMed ID: 22874089
[TBL] [Abstract][Full Text] [Related]
3. Screening of benzalkonium chloride resistance in Listeria monocytogenes strains isolated during cold smoked fish production.
Soumet C; Ragimbeau C; Maris P
Lett Appl Microbiol; 2005; 41(3):291-6. PubMed ID: 16108923
[TBL] [Abstract][Full Text] [Related]
4. [Investigation of the effect of efflux pump inhibitors to MIC values of ciprofloxacin in clinical isolates of Pseudomonas aeruginosa, Escherichia coli, Acinetobacter baumannii and Staphylococcus aureus].
Cetinkaya E; Coban AY; Durupinar B
Mikrobiyol Bul; 2008 Oct; 42(4):553-61. PubMed ID: 19149076
[TBL] [Abstract][Full Text] [Related]
5. The action of Pseudomonas aeruginosa biofilms in intrinsic drug resistance.
Xie Y; Jia WX; Zeng W; Yang WQ; Cheng X; Li XR; Wang LL; Kang M; Zhang ZR
Chin Med J (Engl); 2005 Oct; 118(19):1615-22. PubMed ID: 16232346
[TBL] [Abstract][Full Text] [Related]
6. Adaptive response of single and binary Pseudomonas aeruginosa and Escherichia coli biofilms to benzalkonium chloride.
Machado I; Lopes SP; Sousa AM; Pereira MO
J Basic Microbiol; 2012 Feb; 52(1):43-52. PubMed ID: 21780153
[TBL] [Abstract][Full Text] [Related]
7. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
8. The role of active efflux in antibiotic - resistance of clinical isolates of Helicobacter pylori.
Falsafi T; Ehsani A; Niknam V
Indian J Med Microbiol; 2009; 27(4):335-40. PubMed ID: 19736403
[TBL] [Abstract][Full Text] [Related]
9. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
Hill D; Rose B; Pajkos A; Robinson M; Bye P; Bell S; Elkins M; Thompson B; Macleod C; Aaron SD; Harbour C
J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
[TBL] [Abstract][Full Text] [Related]
10. Comparison of antibiotic susceptibility and plasmid content, between biofilm producing and non-producing clinical isolates of Pseudomonas aeruginosa.
Delissalde F; Amábile-Cuevas CF
Int J Antimicrob Agents; 2004 Oct; 24(4):405-8. PubMed ID: 15380270
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Pseudomonas aeruginosa isolated from clinical and environmental samples in Minia, Egypt: prevalence, antibiogram and resistance mechanisms.
Gad GF; El-Domany RA; Zaki S; Ashour HM
J Antimicrob Chemother; 2007 Nov; 60(5):1010-7. PubMed ID: 17906321
[TBL] [Abstract][Full Text] [Related]
12. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa.
Pasquali F; Manfreda G
Vet Microbiol; 2007 Jan; 119(2-4):304-10. PubMed ID: 16987619
[TBL] [Abstract][Full Text] [Related]
13. [Effect of efflux pump inhibitor 1-(1-naphthylmethyl)-piperazine to MIC values of ciprofloxacin in ciprofloxacin resistant gram-negative bacteria].
Coban AY; Bayram Z; Sezgin FM; Durupinar B
Mikrobiyol Bul; 2009 Jul; 43(3):457-61. PubMed ID: 19795621
[TBL] [Abstract][Full Text] [Related]
14. Adaptation of Pseudomonas aeruginosa clinical isolates to benzalkonium chloride retards its growth and enhances biofilm production.
El-Banna T; Abd El-Aziz A; Sonbol F; El-Ekhnawy E
Mol Biol Rep; 2019 Jun; 46(3):3437-3443. PubMed ID: 30972606
[TBL] [Abstract][Full Text] [Related]
15. Characterization of clonal strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients in Ontario, Canada.
Beaudoin T; Aaron SD; Giesbrecht-Lewis T; Vandemheen K; Mah TF
Can J Microbiol; 2010 Jul; 56(7):548-57. PubMed ID: 20651854
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone resistance of Pseudomonas aeruginosa isolates causing nosocomial infection is correlated with levofloxacin but not ciprofloxacin use.
Lee YJ; Liu HY; Lin YC; Sun KL; Chun CL; Hsueh PR
Int J Antimicrob Agents; 2010 Mar; 35(3):261-4. PubMed ID: 20045290
[TBL] [Abstract][Full Text] [Related]
17. Contribution of efflux pumps in fluroquinolone resistance in multi-drug resistant nosocomial isolates of Pseudomanas aeruginosa from a tertiary referral hospital in north east India.
Choudhury D; Talukdar AD; Maurya AP; Choudhury MD; Dhar Chanda D; Chakravarty A; Bhattacharjee A
Indian J Med Microbiol; 2015; 33(1):84-6. PubMed ID: 25560007
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
19. Determination of the efflux pump-mediated resistance prevalence in Pseudomonas aeruginosa, using an efflux pump inhibitor.
Tohidpour A; Najar Peerayeh S; Mehrabadi JF; Rezaei Yazdi H
Curr Microbiol; 2009 Sep; 59(3):352-5. PubMed ID: 19554368
[TBL] [Abstract][Full Text] [Related]
20. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
Prasad SV; Ballal M; Shivananda PG
Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
